GASTROINTESTINAL CANCERS
Clinical trials for GASTROINTESTINAL CANCERS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL CANCERS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for stomach cancer: experimental drug BHB810 enters human trials
Disease control Not yet recruitingThis study tests a new drug called BHB810 in adults with advanced stomach or gastroesophageal junction cancer that has not responded to standard treatments. The drug is given as an IV infusion every two weeks. The main goals are to check safety, find the best dose, and see if it …
Matched conditions: GASTROINTESTINAL CANCERS
Phase: PHASE1, PHASE2 • Sponsor: BigHat Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 07:54 UTC
-
New combo therapy aims to control advanced cancers in real-world study
Disease control Not yet recruitingThis study looks at how safe and effective a drug called adebrelimab is when combined with other treatments for people with advanced solid tumors, including lung and gastrointestinal cancers. About 300 participants will be observed in real-world settings to track side effects and…
Matched conditions: GASTROINTESTINAL CANCERS
Sponsor: Tianjin First Central Hospital • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
AI tool aims to speed up Post-Surgery recovery decisions
Knowledge-focused Not yet recruitingAfter gastrointestinal or cancer surgery, it's hard to know when a patient is ready for rehab or discharge. This study tests an AI tool that uses routine hospital data to give a simple yes/no answer to help doctors decide. About 103 adults will take part, and the tool won't repla…
Matched conditions: GASTROINTESTINAL CANCERS
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 07:53 UTC
-
A randomized, double-blind, placebo-controlled, prospective, multi-center trial evaluating the improvement of nutritional status and sarcopenia with silkworm pupa tablets in patients with malignancies
Not yet recruitingThis is a randomized, double-blind, placebo-controlled, parallel-group, prospective, multi-center clinical trial, to evaluate the efficacy of silkworm pupa tablets in improving nutritional status and sarcopenia in patients with malignancies who have completed comprehensive treatm…
Matched conditions: GASTROINTESTINAL CANCERS
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University
Last updated May 11, 2026 20:49 UTC